Showing 2831-2840 of 3329 results for "".
- Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feethttps://modernaesthetics.com/news/revances-daxibotulinumtoxina-for-injection-looks-good-in-phase-2-studies-of-forehead-lines-and-crows-feet/2472963/Revance Therapeutics, Inc.’s next-generation neuromodulator product, DaxibotulinumtoxinA, safely and effectively smoothed forehead lines and Crow’s feet with a median duration of 27 weeks in forehead lines and 24 weeks in crow’s feet achieved in at least one treatment group
- Sciton’s New mJOULE Platform Features BBL HERO and MOXIhttps://modernaesthetics.com/news/scitons-new-mjoule-platform-features-bbl-hero-and-moxi/2472952/Sciton Inc. is rolling out their mJOULE dual-wavelength platform which includes a new fractional treatment, MOXI, and BBL HERO. MOXI delivers non-ablative laser energy to revitalize skin and BroadBand Light HERO (High Energy Rapid Output) allows practitioners to treat the entire body wi
- Obagi Rolls Out Two New Sunscreens and a Serumhttps://modernaesthetics.com/news/obagi-drops-two-new-sunscreens-and-a-serum-1/2472950/Obagi is launching two new Physical Defense Sunscreens and Daily Hydro-Drops. The new SUZANOBAGIMD Physical Defense Sunscreens, available in broad-spectrum SPF 40 and tinted SPF 50, defend against five light sources, including high energy visible light, or blue light, visible light
- Patients Treated with Dysport Highly Satisfied with Twice-Yearly Treatmentshttps://modernaesthetics.com/news/patients-treated-with-dysport-highly-satisfied-with-twice-yearly-treatments/2472933/Topline results of DREAM (Dysport Real-world Evaluation and Measured satisfaction study), a clinical study of Dysport (abobotulinumtoxinA) for injection, showed that 95 percent of patients treated with Dysport achieved high levels of satisfaction with two treatments per
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co
- Industry Responds to COVID-19: Galderma, Timeless Skin Care, UCBhttps://modernaesthetics.com/news/industry-responds-to-covid-19-galderma-timeless-skin-care-ucb/2472915/Galderma. Galderma is offering educational webinars to support aesthetic customers during the pandemic. Galderma Italy donated Cetaphil hydrating lotion to hospitals and are also set to
- Demystified: Your Insurance Coverage During COVID-19https://modernaesthetics.com/news/demystified-your-insurance-coverage-during-covid-19/2472913/Jason O’Dell, a financial consultant and insurance specialist at OJM Group, spoke with New Jersey-based dermatologist Jeanine Downie, MD and Chicagoland facial plastic surgeon Steve Dayan, MD about what to expect from insurance coverage during the pandemic and how to beef up your policies i
- Industry Responds to COVID-19: PCA Skin, Henry Schein Medicalhttps://modernaesthetics.com/news/industry-responds-to-covid-19-pca-skin-henry-schein-medical/2472910/PCA Skin. PCA Skin®is partnering with FABRIC and its non-profit AZ Apparel Foundation that is using their resources to produce FDA-approved Personal Protective Equipment (PPE) during the COVID-19 health emergency. From April 13 to 30, PCA Skin will donate
- Facial Plastic Surgeons Respond to COVID-19, Part II: Taking Care of Patients and Staffhttps://modernaesthetics.com/news/part-ii-facial-plastic-surgeons-respond-to-covid-19-taking-care-of-patients-and-staff/2472909/With calls to cancel all elective procedures and widespread stay-at-home orders in place, COVID-19 has dramatically upended the practice of facial plastic surgery in the US and abroad. Here, two American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) board members di
- Facial Plastic Surgeons Respond to COVID-19: “We Will Get Through This...Whatever It Takes”https://modernaesthetics.com/news/facial-plastic-surgeons-respond-to-covid-19-we-will-get-through-thiswhatever-it-takes/2472902/All health care professionals are doing what they can to help Americans cope with the COVID-19 pandemic. For facial plastic surgeons, COVID-19 has caused an upheaval in their professional lives with office closures and the postponement of all elective procedures. The CARES Act is h